Biocryst Pharmaceuticals (BCRX) Tax Rate (2021 - 2026)
Biocryst Pharmaceuticals' (BCRX) quarterly Tax Rate came in at 0.14% in Q1 2026, down 9592.0% YoY from 0.0% in Q1 2025, and down 115.91% on a QoQ basis from 0.88% in Q4 2025.
Biocryst Pharmaceuticals (BCRX) Tax Rate (2021 - 2026) Analysis & Trends
Biocryst Pharmaceuticals (BCRX) has 6 years of Tax Rate data on file, last reported at 0.14% in Q1 2026.
- Quarterly Tax Rate fell 9592.0% year-over-year to 0.14% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.84% (up 363.0% YoY) and the FY2025 annual result came in at 1.32%, up 354.0% from the prior year.
- Tax Rate slipped to 0.14% in Q1 2026, from 0.88% in the prior quarter.
- In the past five years, Tax Rate ranged from a high of 95.78% in Q1 2025 to a low of 6.34% in Q3 2025.
- A 5-year average of 5.61% and a median of 0.99% in 2023 frame the typical range for Tax Rate.
- Annual changes were most pronounced in 2025 — Tax Rate surged 9682 bps — and 2026, when it sank 9592 bps.
- Tracing BCRX's Tax Rate over 5 years: stood at 0.11% in 2022, then surged by 2230 bps to 2.27% in 2023, then tumbled by 237 bps to 3.09% in 2024, then jumped by 128 bps to 0.88% in 2025, then tumbled by 116 bps to 0.14% in 2026.
- The last three Tax Rate figures came in at 0.14% (Q1 2026), 0.88% (Q4 2025), and 6.34% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.81 Bn | 42.84 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.29 Bn | 39.63 Bn | 2.15 Bn | -26.59% |
| 3 | Zoetis | 31.59 Bn | 29.91 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.88 Bn | 5.10 Bn | -30.40% |
| 5 | United Therapeutics | 22.24 Bn | 19.58 Bn | 683.80 Mn | 10.65% |
| 6 | Viatris | 18.79 Bn | 17.91 Bn | 1.46 Bn | -85.63% |
| 7 | Neurocrine Biosciences | 15.71 Bn | 15.32 Bn | 935.80 Mn | 10.97% |
| 8 | Elanco Animal Health | 12.09 Bn | 11.56 Bn | 798.00 Mn | 3.57% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Biocryst Pharmaceuticals | 2.45 Bn | 2.10 Bn | 214.41 Mn | 1.36% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.36% |
| Jun 30, 2026 | 1.36% |
| Jun 30, 2026 | 1.36% |
| Mar 31, 2026 | -0.14% |
| Mar 31, 2026 | -0.14% |
| Mar 31, 2026 | -0.14% |
| Dec 31, 2025 | 0.88% |
| Dec 31, 2025 | 0.88% |
| Dec 31, 2025 | 0.88% |
| Sep 30, 2025 | -6.34% |
| Sep 30, 2025 | -6.34% |
| Sep 30, 2025 | -6.34% |
| Jun 30, 2025 | 21.60% |
| Jun 30, 2025 | 21.60% |
| Jun 30, 2025 | 21.60% |
| Mar 31, 2025 | 95.78% |
| Mar 31, 2025 | 95.78% |
| Mar 31, 2025 | 95.78% |
| Dec 31, 2024 | -3.09% |
| Dec 31, 2024 | -3.09% |